Risk of RBC alloimmunization in multiple myeloma patients treated by Daratumumab
Zhan Ye, Laurie A. Wolf, Daniel Mettman, Fred V. Plapp - 14/11/2019
Relevance and costs of RHD genotyping in women with a weak D phenotype
L. Laget, C. Izard, E. Durieux-Roussel, J. Gouvitsos, I. Dettori, J. Chiaroni, V. Ferrera-Tourenc - 23/01/2019
A novel c.166A>T (p.Thr56Ser) mutation in GYPB*S accounting for unusual S antigen expression
Yumi Suzuki, Kazumi Isa, Kenichi Ogasawara, Yuika Kikuchi, Ryuichi Yabe, Nelson-Hirokazu Tsuno, Mako - 06/12/2018
Anti-D quantification in relation to anti-D titre, middle cerebral artery Doppler measurement and clinical outcome in RhD-immunized pregnancies
Agneta Wikman, Elisabeth Jalkesten, Gunilla Ajne, Petter Höglund, Anette Mörtberg, Eleonor Tiblad - 11/10/2018
Comparison of the tube test and column agglutination techniques for anti-A/-B antibody titration in healthy individuals
Hideaki Matsuura, Yoshiki Akatsuka, Takahiro Matsuno, Yukari Sugiura, Shoko Arakaw, Shota Oikawa, Ju - 24/09/2018
Performance evaluation study of ID RHD XT, a new genotyping assay for the detection of high-prevalence RhD negative and weak D types
Araitz Molano, Izaskun Apraiz, Patricia Espa?a, Maria Azkarate, Miguel ?ngel Vesga, Montserrat Rubia - 19/08/2018
Thirty-three-day storage of dithiothreitol-treated red blood cells used to eliminate daratumumab interference in serological testing
Henriette Lorenzen, Nazia Lone Akhtar, Maria Nielsen, Lea Svendsen, Pernille Andersen - 25/07/2018
A novel mutation +5904 C>T of RUNX1 site in the erythroid cell-specific regulatory element decreases the ABO antigen expression in Chinese population
Y. Ying, X. Hong, X. Xu, K. Ma, J. He, F. Zhu - 05/07/2018
Extending shelf life of dithiothreitol-treated panel RBCs to 28 days
J.-P. Sigle, B. Mihm, R. Suno, M. Bargetzi - 07/03/2018